FDA Inspection 1035729 — Mayne Pharma International PTY LTD
The FDA completed an inspection of Mayne Pharma International PTY LTD on Sep 15, 2017 in Salisbury South. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Salisbury South (Australia)